Seres Therapeutics Announces Appointment of Richard N. Kender as Executive Chair and Interim CEO; Provides Business Updates

Weekly Voice editorial staff
0 Min Read

Accomplished pharmaceutical executive brings extensive business development, licensing and finance experience

- Advertisement -
Share This Article